Business
Board change
Genedrive plc announces that Dr. Ian Gilham has stepped down as Chairman and a Director, as previously indicated in the May 26, 2026 announcement. The company is actively recruiting for a new independent Non-Executive Chairman and two additional independent Non-Executive Directors, with further updates expected. Chris Yates continues to serve as an independent Non-Executive Director during this transition period. Disclaimer*
About this update from Genedrive Plc
1 July 2026 genedrive plc ("genedrive" or the "Company") Board change genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, today announces that further to the Company's announcement of 26 May 2026 detailing various immediate and proposed board changes, Dr. Ian Gilham, Chairman and a Director of genedrive, has today stepped down from the Board. The recruitment process for a new independent Non-Executive Chairman as well as two other independent Non-Executive Directors is progressing and further announcements will be made in due course. As also confirmed in the 26 May 2026 announcement, Chris Yates continues to act as an independent Non-Executive Director pending the appointment of new Non-Executive Board members. Gino Miele, CEO of genedrive plc, said: "I would like to thank Ian for his commitment to genedrive and for the invaluable contributions he has made over many years in helping to shape the Company and its mission to transform patient outcomes through rapid pharmacogenetic testing. On behalf of the Board and the entire team at genedrive, both past and present, I wish him every success for the future. We look forward to welcoming our new Non-Executive Chairman and Non-Executive Directors and will update the market in due course." genedrive plc +44 (0)161 989 0245 Gino Miele: CEO / Russ Shaw: CFO https://investors.genedrive.com/s/e0025c Peel Hunt LLP (Nominated Adviser and Broker) ...